Symptom score, exercise capacity, and quality of life were significantly higher in the ablation group.
消融组的症状分数、运动能力和生活质量都要显著高些。
In this group, the therapeutic benefit of TOLAMBA in reducing total nasal symptom scores was evident, as reflected in a clinically meaningful reduction of TNSS in the treated patients.
在这个组，TOLAMBA减低全部鼻症状评分从而对治疗有利是显然的，正如被治疗的患者临床上全部鼻症状评分减少所反映的深长意义一样。
Results The morbidity of hypertension, diabetes mellitus , atypical symptom MI, severe arrhythmia and shock were higher in senile group(P< 0.05).
结果老年组中高血压、糖尿病、不典型症状、严重心律失常、休克、接受保守治疗均高于非老年组（P<0.05）。
应用推荐